Latest News about Biotech
Recent news which mentions Biotech
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
From Benzinga
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
December 21, 2023
From Benzinga
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
From Benzinga
From Benzinga
European Drugmaker Sanofi Ends Tusamitamab Ravtansine Lung Cancer Program After Disappointing Data
December 21, 2023
Tickers
SNY
From Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
From Benzinga
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today?
December 20, 2023
From Benzinga
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
December 20, 2023
Tickers
ANIX
From Benzinga
RedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola
December 20, 2023
From Benzinga
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
December 20, 2023
Tickers
BCTX
From Benzinga
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
December 20, 2023
Tickers
DARE
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study
December 20, 2023
Tickers
ACRS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.